Abstract:Background. Berberine, an isoquinoline alkaloid derived from plants, has been used as a traditional medicine for several diseases, including bacterial diarrhea. Recently, Berberine has been shown to suppress tumor cell growth and regulate several signaling pathways involved in apoptosis and cell cycle arrest In Vitro. However information is limited regarding mechanisms of Berberine's action in diseases. This study was designed to investigate Berberine's anti-tumor and anti-inflammatory effects. Methods. 7 patients with familial adenomatous polyposis history and recurrent colon adenomatous polyps were enrolled for oral Berberine treatment (0.1 g, 3 times/day) immediately following polypectomy and patients followed-up up to two years. Animal studies were performed on C57BL/6 mice administered 3% DSS in drinking water, or water only, for 7 days. Mice were given Berberine (200 μg/ g body weight, once daily) via gavage from day 4-7. Colon sections were prepared for H&E staining to determine intestinal tissue injury score (0: normal, 18: severe colitis). Mouse colon epithelial cells derived from wt Immorto (YAMC), Immorto-Min mice carrying APC min mutation (IMCE), and IMCE cells over-expression of Ras (IRas) were treated with Berberine (25 μM 200 μM) in the presence or absence of TNF (100 ng/ml), EGF (10 ng/ ml) or caspase inhibitor for detecting apoptosis using Annexin staining and TUNEL assay, signaling by Western blot analysis, and colony formation in agar. Results. 6 (7 total) patients showed no recurrence of polyps during the 2-year Berberine treatment. Berberine induced apoptosis in IMCE and IRas, but not YAMC cells and inhibited IRas cell colony formation in a concentration-dependent manner. Berberine stimulated p53 activation and blocked TNF-induced NFκB activation. In addition, Berberine inhibited EGF-stimulated EGF receptor activation and cell proliferation. However, Berbeine did not activate caspase 3 or 9 nor did the caspase inhibitor prevent Berberine-induced apoptosis. DSS-induced colitis (score: 15±0.9) was significantly reduced by Berberine treatment (score: 10±1.3, p<0.05). Conclusion. Berberine exerts the anti-tumor effect, which may be through induction of tumor cell apoptosis and inhibition of the action of tumor-promoting factors, including EGF and TNF. In addition, anti-inflammatory effects of Berberine may contribute to prevention of colitisassociated tumor development. The role of p53 activation and NFκB inhibition by Berberine in prevention of tumor development and inflammation is under investigation. Thus, Berberine may serve as a potential alternative approach for treating intestinal inflammatory diseases and tumor development.

A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apcam1137)

A flavonoid-rich extract of bergamot juice improves high-fat diet-induced intestinal permeability and associated hepatic damage in mice

Pomegranate By-Products in Colorectal Cancer Chemoprevention: Effects in Apc-Mutated Pirc Rats and Mechanistic Studies In Vitro and Ex Vivo

Functional Anthocyanin-Rich Sausages Diminish Colorectal Cancer in an Animal Model and Reduce Pro-Inflammatory Bacteria in the Intestinal Microbiota

Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota

Phytic acid improves intestinal mucosal barrier damage and reduces serum levels of proinflammatory cytokines in a 1,2-dimethylhydrazine-induced rat colorectal cancer model

Berberis vulgaris L. Root Extract as a Multi-Target Chemopreventive Agent against Colon Cancer Causing Apoptosis in Human Colon Adenocarcinoma Cell Lines

Proanthocyanidin and sodium butyrate synergistically modulate rat colon carcinogenesis by scavenging free radicals and regulating the COX-2 and APC pathways

Effect of 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine on oxidative stress and gene expression of c-fos, c-jun, p16 and Rb in rat colons and protective role of seabuckthorn seed oil

Ameliorating Intestinal Inflammation and Preventing Colon Tumor Development by the Plant Extract, Berberine

Microencapsulated Bifidobacterium bifidum and Lactobacillus gasseri in Combination with Quercetin Inhibit Colorectal Cancer Development in ApcMin/+ Mice

Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines

The anticancer effects of Aronia berry extract are mediated by Chk1 and p53 in colorectal cancer

Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats

Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula

Inhibitory Effect Of Apigenin On Benzo(A)Pyrene-Mediated Genotoxicity In Swiss Albino Mice

Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model

Chemopreventive Effects of Nobiletin and Its Colonic Metabolites on Colon Carcinogenesis

Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model

Dietary Polyacetylenic Oxylipins Falcarinol and Falcarindiol Prevent Inflammation and Colorectal Neoplastic Transformation: A Mechanistic and Dose-Response Study in A Rat Model

Chemopreventive effects of berberine on intestinal tumor development in Apc min/+ mice